{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:24:29Z","timestamp":1789575869721,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UL1-TR-000040"],"award-info":[{"award-number":["UL1-TR-000040"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UL1-TR-001420"],"award-info":[{"award-number":["UL1-TR-001420"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UL1-TR-001079"],"award-info":[{"award-number":["UL1-TR-001079"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pcad.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:19:04Z","timestamp":1741724344000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA"],"prefix":"10.1016","volume":"89","author":[{"given":"Muhammad Imtiaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag A.","family":"Chevli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Mirzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Rikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpeet","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ruddiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared A.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2025.03.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100651","article-title":"High lipoprotein(a): actionable strategies for risk assessment and mitigation","volume":"18","author":"Reyes-Soffer","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.pcad.2025.03.001_bb0010","first-page":"27","article-title":"All we need to know about lipoprotein(a)","volume":"84","author":"Bess","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.pcad.2025.03.001_bb0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/M19-0365","article-title":"Cholesterol Clinical Practice Guidelines: synopsis of the 2018 American Heart Association\/American College of Cardiology\/Multisociety Cholesterol Guideline","volume":"170","author":"Grundy","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2025.03.001_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pcad.2022.01.002","article-title":"Global think tank on the clinical considerations and management of lipoprotein(a): the top questions and answers regarding what clinicians need to know","volume":"73","author":"Virani","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2025.03.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2024.06.005","article-title":"What\u2019s next for lipoprotein(a)? A national lipid association report from an expert panel discussion","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2025.03.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.pcad.2025.03.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008507","article-title":"Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK biobank","volume":"7","author":"Peters","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.pcad.2025.03.001_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jama.2016.21042","article-title":"Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease","volume":"317","author":"Emdin","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pcad.2025.03.001_bb0045","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the National Lipid Association 2024","volume":"18","author":"Bays","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.pcad.2025.03.001_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jacl.2020.12.002","article-title":"Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)","volume":"15","author":"Ho","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2025.03.001_bb0055","doi-asserted-by":"crossref","first-page":"8435133","DOI":"10.1155\/2022\/8435133","article-title":"The effect of bariatric surgery on circulating levels of lipoprotein (a): a meta-analysis","volume":"2022","author":"Jamialahmadi","year":"2022","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.pcad.2025.03.001_bb0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12872-020-01626-7","article-title":"Interaction between lipoprotein (a) levels and body mass index in first incident acute myocardial infarction","volume":"20","author":"Teng","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.pcad.2025.03.001_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2021.11.043","article-title":"Lipoprotein(a) and body mass compound the risk of calcific aortic valve disease","volume":"79","author":"Kaltoft","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2025.03.001_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.03.001_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jacc.2021.07.016","article-title":"High-sensitivity C-reactive protein modifies the cardiovascular risk of lipoprotein(a): multi-ethnic study of atherosclerosis","volume":"78","author":"Zhang","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2025.03.001_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2021.11.043","article-title":"Lipoprotein(a) and body mass compound the risk of calcific aortic valve disease","volume":"79","author":"Kaltoft","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.pcad.2025.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.03.001_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2022.04.005","article-title":"Lipoprotein(a) and ethnicities","volume":"349","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.pcad.2025.03.001_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","article-title":"Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis","volume":"22","author":"Moriarty","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"11","key":"10.1016\/j.pcad.2025.03.001_bb0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","article-title":"Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1","volume":"28","author":"Skurk","year":"2004","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.pcad.2025.03.001_bb0105","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.1038\/s41598-022-21121-7","article-title":"Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents","volume":"12","author":"Liu","year":"2022","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.pcad.2025.03.001_bb0110","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women role of inflammation and oxidant stress","volume":"288","author":"Dav\u00ec","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.pcad.2025.03.001_bb0115","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2022.07.027","article-title":"Aspirin for primary prevention of cardiovascular events in relation to lipoprotein(a) genotypes","volume":"80","author":"Lacaze","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.03.001_bb0120","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.pcad.2025.03.001_bb0125","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jamacardio.2020.2413","article-title":"Effect of C-reactive protein on lipoprotein(a)-associated cardiovascular risk in optimally treated patients with high-risk vascular disease: a prespecified secondary analysis of the ACCELERATE trial","volume":"5","author":"Puri","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"16","key":"10.1016\/j.pcad.2025.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehad055","article-title":"Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein","volume":"44","author":"Thomas","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.03.001_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2016.11.010","article-title":"Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: the EPIC-Norfolk prospective population study","volume":"256","author":"Perrot","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2025.03.001_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pcad.2023.07.006","article-title":"Lipoprotein(a) in clinical practice: a guide for the clinician","volume":"79","author":"Krittanawong","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"9497","key":"10.1016\/j.pcad.2025.03.001_bb0145","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"The Lancet"},{"issue":"25","key":"10.1016\/j.pcad.2025.03.001_bb0150","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.106.673756","article-title":"Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk cohort","volume":"116","author":"Canoy","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pcad.2025.03.001_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jacc.2008.03.066","article-title":"Measures of obesity and cardiovascular risk among men and women","volume":"52","author":"Gelber","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2025.03.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008507","article-title":"Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK biobank","volume":"7","author":"Peters","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2025.03.001_bb0165","article-title":"Is BMI the best measure of obesity?","volume":"360","author":"Adab","year":"2018","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.pcad.2025.03.001_bb0170","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:04:35Z","timestamp":1762218275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062025000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":34,"alternative-id":["S0033062025000301"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2025.03.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}